A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension

AU Klingbeil, M Schneider, P Martus… - The American journal of …, 2003 - Elsevier
PURPOSE: Antihypertensive medications have different effects on left ventricular mass. We
conducted a meta-analysis of double-blind trials that measured the effects of …

LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice

AC Armstrong, S Gidding, O Gjesdal, C Wu… - JACC: Cardiovascular …, 2012 - jacc.org
The authors investigated 3 important areas related to the clinical use of left ventricular mass
(LVM): accuracy of assessments by echocardiography and cardiac magnetic resonance …

2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension …

G Mancia, G De Backer, A Dominiczak… - European heart …, 2007 - academic.oup.com
Recommendations about therapy for hypertension are here preceded by some
considerations on the strength of available evidence on the benefits associated with …

2003 European Society of Hypertension–European Society of Cardiology guidelines for the management of arterial hypertension

Guidelines Committee - Journal of hypertension, 2003 - journals.lww.com
2003 European Society of Hypertension–European Society of Ca... : Journal of
Hypertension 2003 European Society of Hypertension–European Society of Cardiology …

Prognostic implications of left ventricular hypertrophy

BA Vakili, PM Okin, RB Devereux - American heart journal, 2001 - Elsevier
Background To date there has been no comprehensive review of the association between
left ventricular hypertrophy (LVH) at baseline and subsequent adverse clinical events …

Prognostic significance of left ventricular mass change during treatment of hypertension

RB Devereux, K Wachtell, E Gerdts, K Boman… - Jama, 2004 - jamanetwork.com
ContextIncreased baseline left ventricular (LV) mass predicts cardiovascular (CV)
complications of hypertension, but the relation between lower LV mass and outcome during …

Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension

G Schillaci, P Verdecchia, C Porcellati, O Cuccurullo… - …, 2000 - Am Heart Assoc
The detection of left ventricular (LV) hypertrophy on echocardiography is a powerful risk
indicator in essential hypertension. However, the prognostic impact of LV mass values within …

Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study

GM London, B Pannier, AP Guerin… - Journal of the …, 2001 - journals.lww.com
Left ventricular (LV) hypertrophy (LVH) is a risk factor for mortality in patients with end-stage
renal disease (ESRD). Whether the attenuation of LVH has a positive effect on survival of …

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril

J Mathew, P Sleight, E Lonn, D Johnstone, J Pogue… - Circulation, 2001 - Am Heart Assoc
Background Electrocardiographic markers of left ventricular hypertrophy (LVH) predict poor
prognosis. We determined whether the ACE inhibitor ramipril prevents the development and …

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) …

RB Devereux, B Dahlöf, E Gerdts, K Boman… - Circulation, 2004 - Am Heart Assoc
Background—An echocardiographic substudy of the Losartan Intervention for Endpoint
Reduction in Hypertension (LIFE) trial was designed to test the ability of losartan to reduce …